Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Total Liabilities (2016 - 2025)

Bio Key International (BKYI) has disclosed Total Liabilities for 16 consecutive years, with $4.1 million as the latest value for Q3 2025.

  • Quarterly Total Liabilities fell 35.08% to $4.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Sep 2025, down 35.08% year-over-year, with the annual reading at $4.8 million for FY2024, 40.25% up from the prior year.
  • Total Liabilities hit $4.1 million in Q3 2025 for Bio Key International, up from $3.7 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $6.7 million in Q2 2023 to a low of $1.9 million in Q1 2021.
  • Historically, Total Liabilities has averaged $4.3 million across 5 years, with a median of $4.0 million in 2022.
  • Biggest five-year swings in Total Liabilities: tumbled 57.99% in 2021 and later soared 180.59% in 2022.
  • Year by year, Total Liabilities stood at $2.2 million in 2021, then skyrocketed by 180.59% to $6.0 million in 2022, then crashed by 42.85% to $3.5 million in 2023, then skyrocketed by 40.25% to $4.8 million in 2024, then fell by 16.01% to $4.1 million in 2025.
  • Business Quant data shows Total Liabilities for BKYI at $4.1 million in Q3 2025, $3.7 million in Q2 2025, and $3.7 million in Q1 2025.